Houston Methodist Research Institute, Houston Methodist Hospital and Department of Pathology and Genomic Medicine present:

 Cancer Biomarkers Conference 

Program Directors:

Philip T. Cagle, M.D., Medical Director, Pulmonary Pathology, Department of Pathology and Genomic Medicine, Houston Methodist Hospital and Houston Methodist Research Institute

Randall J. Olsen, M.D., Ph.D., Medical Director, Molecular Diagnostics, Department of Pathology and Genomic Medicine, Houston Methodist Hospital and Houston Methodist Research Institute

 Associate Program Directors:

Bryce P. Portier, M.D., Ph.D., Medical Director, Solid Tumor Molecular Diagnostics, Department of Pathology and Genomic Medicine, Houston Methodist Hospital and Houston Methodist Research Institute

Hidehiro Takei, M.D., Medical Director, Autopsy Service, Associate Medical Director, Neuropathology, Department of Pathology and Genomic Medicine, Houston Methodist Hospital

Overview:

Pathologists and oncologists require updated knowledge in the rapidly developing field of biomarkers to offer the best patient care. This one-day conference will provide a timely overview of predictive biomarkers in major solid tumors and biomarker reporting, oriented toward practical clinical application for pathologists, oncologists and others who care for cancer patients.

Please visit the official website at http://cancer-biomarkers.org/.